Live feed09:30:00·198dPRReleasevia QuantisnowIncyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025ByQuantisnow·Wall Street's wire, on your screen.INCY· Incyte Corp.Health Care
